BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 12834342)

  • 1. The structure of the membrane distal phosphatase domain of RPTPalpha reveals interdomain flexibility and an SH2 domain interaction region.
    Sonnenburg ED; Bilwes A; Hunter T; Noel JP
    Biochemistry; 2003 Jul; 42(26):7904-14. PubMed ID: 12834342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible oxidation of the membrane distal domain of receptor PTPalpha is mediated by a cyclic sulfenamide.
    Yang J; Groen A; Lemeer S; Jans A; Slijper M; Roe SM; den Hertog J; Barford D
    Biochemistry; 2007 Jan; 46(3):709-19. PubMed ID: 17223692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the membrane distal catalytic domain in pervanadate-induced tyrosine phosphorylation of receptor protein-tyrosine phosphatase alpha.
    Buist A; Blanchetot C; den Hertog J
    Biochem Biophys Res Commun; 2000 Jan; 267(1):96-102. PubMed ID: 10623581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of potent protein-tyrosine phosphatase activity into the membrane-distal domain of receptor protein-tyrosine phosphatase alpha.
    Buist A; Zhang YL; Keng YF; Wu L; Zhang ZY; den Hertog J
    Biochemistry; 1999 Jan; 38(3):914-22. PubMed ID: 9893986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalytically active membrane-distal phosphatase domain of receptor protein-tyrosine phosphatase alpha is required for Src activation.
    Vacaru AM; den Hertog J
    FEBS J; 2010 Mar; 277(6):1562-70. PubMed ID: 20158519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RPTPα phosphatase activity is allosterically regulated by the membrane-distal catalytic domain.
    Wen Y; Yang S; Wakabayashi K; Svensson MND; Stanford SM; Santelli E; Bottini N
    J Biol Chem; 2020 Apr; 295(15):4923-4936. PubMed ID: 32139509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2.
    Eck MJ; Pluskey S; Trüb T; Harrison SC; Shoelson SE
    Nature; 1996 Jan; 379(6562):277-80. PubMed ID: 8538796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the hematopoietic tyrosine phosphatase (HePTP) catalytic domain: structure of a KIM phosphatase with phosphate bound at the active site.
    Mustelin T; Tautz L; Page R
    J Mol Biol; 2005 Nov; 354(1):150-63. PubMed ID: 16226275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tight association of GRB2 with receptor protein-tyrosine phosphatase alpha is mediated by the SH2 and C-terminal SH3 domains.
    den Hertog J; Hunter T
    EMBO J; 1996 Jun; 15(12):3016-27. PubMed ID: 8670803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phosphatase domains of LAR, CD45, and PTP1B: structural correlations with peptide-based inhibitors.
    Glover NR; Tracey AS
    Biochem Cell Biol; 2000; 78(1):39-50. PubMed ID: 10735562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The three-dimensional solution structure of the SH2 domain from p55blk kinase.
    Metzler WJ; Leiting B; Pryor K; Mueller L; Farmer BT
    Biochemistry; 1996 May; 35(20):6201-11. PubMed ID: 8639560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of the phosphorylation of receptor tyrosine phosphatase-alpha on the Src-independent site tyrosine 789 by reactive oxygen species.
    Hao Q; Rutherford SA; Low B; Tang H
    Mol Pharmacol; 2006 Jun; 69(6):1938-44. PubMed ID: 16505154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular domain splice variants of a transforming protein tyrosine phosphatase alpha mutant differentially activate Src-kinase dependent focus formation.
    Kapp K; Siemens J; Weyrich P; Schulz JB; Häring HU; Lammers R
    Genes Cells; 2007 Jan; 12(1):63-73. PubMed ID: 17212655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptidyl aldehydes as reversible covalent inhibitors of SRC homology 2 domains.
    Park J; Fu H; Pei D
    Biochemistry; 2003 May; 42(17):5159-67. PubMed ID: 12718560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple interactions between receptor protein-tyrosine phosphatase (RPTP) alpha and membrane-distal protein-tyrosine phosphatase domains of various RPTPs.
    Blanchetot C; den Hertog J
    J Biol Chem; 2000 Apr; 275(17):12446-52. PubMed ID: 10777529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
    Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
    Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphopeptide ligands of the SHP-1 N-SH2 domain: effects on binding and stimulation of phosphatase activity.
    Hampel K; Kaufhold I; Zacharias M; Böhmer FD; Imhof D
    ChemMedChem; 2006 Aug; 1(8):869-77. PubMed ID: 16902940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
    Tian M; Martin GS
    Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular dynamics simulations on the free and complexed N-terminal SH2 domain of SHP-2.
    Wieligmann K; Pineda De Castro LF; Zacharias M
    In Silico Biol; 2002; 2(3):305-11. PubMed ID: 12542415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.